Trades on 1 secondary market

Inductive Bio

Inductive Bio is an AI-powered virtual lab for small molecule drug discovery, based in New York and founded in 2022 by Josh Haimson and Ben Birnbaum (both formerly of Flatiron Health). The company pairs medicinal chemists with machine learning to run millions of in silico ADMET (Absorption, Distribu

emerging 15.5 / 100 0 APIs View provider profile →

Company Drug Discovery Machine Learning Artificial Intelligence ADMET Small Molecule

Inductive Bio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.